PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28149280-0	2016	The MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia.	AZD 6244	18-29	interleukin 6	Homo sapiens	66-70	
28149280-6	2016	Moreover, Selumetinib has also been shown to inhibit the production of IL-6.	AZD 6244	10-21	interleukin 6	Homo sapiens	71-75	
28149280-12	2016	Treatment with Selumetinib reduced tumor mass and reduced circulating and tumor IL-6; however MEK inhibition did not preserve muscle mass.	AZD 6244	15-26	interleukin 6	Homo sapiens	80-84